Charlotte L M Krieckaert
Charlotte L M Krieckaert publishes mostly in Rheumatology, Immunology and Radiology, Nuclear Medicine and Imaging, on topics such as Rheumatoid Arthritis Research and Therapies, Biosimilars and Bioanalytical Methods and Spondyloarthritis Studies and Treatments.
- World rank
- #527,043 of 7,710,434 ranked researchers
- Rank in Netherlands
- #12,928 of 107,149
- Works
- 73
- Citations
- 2k
- Citations per work
- 26.9
What does Charlotte L M Krieckaert research?
Charlotte L M Krieckaert's work is mostly in Medicine (66%), Immunology and Microbiology (18%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences4865.9%
- Medicine4865.9%
- Life Sciences1318.4%
- Immunology and Microbiology1318.4%
- Everything else1115.7%
- 1Rheumatology46% of their works
- 2Immunology18% of their works
- 3Radiology, Nuclear Medicine and Imaging7% of their works
- 4Genetics5% of their works
- 5Infectious Diseases5% of their works
- 6Oncology3% of their works
Research topics
- Rheumatoid Arthritis Research and Therapies
- Biosimilars and Bioanalytical Methods
- Spondyloarthritis Studies and Treatments
- Systemic Lupus Erythematosus Research
- Monoclonal and Polyclonal Antibodies Research
- Immunodeficiency and Autoimmune Disorders
- Chronic Lymphocytic Leukemia Research
- Autoimmune and Inflammatory Disorders Research
Which keywords describe Charlotte L M Krieckaert's research?
The keywords of their largest research topics: Autoantibodies, Inflammation, Rheumatoid Arthritis, Monoclonal Antibodies, Biosimilars, Immunogenicity, Ankylosing Spondylitis and Spondyloarthritis.
- Juvenile Idiopathic Arthritis
- Primary Immunodeficiency
- Genetic Mutations
- Therapeutic Antibodies
- Systemic Lupus Erythematosus
- Spondyloarthritis
- Immunogenicity
- Monoclonal Antibodies
- Inflammation
- Autoantibodies
- Rheumatoid Arthritis
- Biosimilars
- Ankylosing Spondylitis
- Antiphospholipid Syndrome
- Fc Receptors
- Chronic Lymphocytic Leukemia
- Genomic Aberrations
- Hemophagocytic Lymphohistiocytosis
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 18 words, with their numbers
- Autoantibodies782 topics
- Inflammation571 topic
- Rheumatoid Arthritis571 topic
- Monoclonal Antibodies402 topics
- Biosimilars241 topic
- Immunogenicity241 topic
- Ankylosing Spondylitis221 topic
- Spondyloarthritis221 topic
- Antiphospholipid Syndrome211 topic
- Systemic Lupus Erythematosus211 topic
- Fc Receptors161 topic
- Therapeutic Antibodies161 topic
- Chronic Lymphocytic Leukemia101 topic
- Genetic Mutations101 topic
- Genomic Aberrations101 topic
- Primary Immunodeficiency101 topic
- Hemophagocytic Lymphohistiocytosis61 topic
- Juvenile Idiopathic Arthritis61 topic
Where does Charlotte L M Krieckaert work?
Charlotte L M Krieckaert's main affiliation in the publication record is Reade, Netherlands.
How many publications and citations does Charlotte L M Krieckaert have?
OpenAlex counts 73 works and 1,966 citations for Charlotte L M Krieckaert, an h-index of 20, ranking #527,043 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Charlotte L M Krieckaert. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.